Equities

Jointown Pharmaceutical Group Co Ltd

Jointown Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (CNY)17.64
  • Today's Change0.04 / 0.23%
  • Shares traded2.77m
  • 1 Year change-4.03%
  • Beta0.1896
Data delayed at least 15 minutes, as of Apr 09 2021 08:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 600998:SHH price moved over -1.01% to 17.62
  • 600998:SHH price rises above 200-day moving average to 17.94 at 10:25 BST
  • 600998:SHH price rises above 50-day moving average to 17.94 at 10:25 BST

Key statistics

On Friday, Jointown Pharmaceutical Group Co Ltd (600998:SHH) closed at 17.64, 10.87% above the 52 week low of 15.91 set on Sep 11, 2020.
52-week range
Today
15.91Sep 11 202020.59Aug 03 2020
Open17.68
High17.80
Low17.52
Bid17.64
Offer17.65
Previous close17.60
Average volume3.82m
Shares outstanding1.87bn
Free float614.72m
P/E (TTM)12.01
Market cap32.98bn CNY
EPS (TTM)1.47
CNY
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateJun 26 2019
Div pay-dateJun 26 2019
Data delayed at least 15 minutes, as of Apr 09 2021 08:00 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.